GlobeNewswire by notified

CORRECTION: Huhtamaki completes the acquisition of Elif, a major supplier of sustainable flexible packaging to global brand owners

Share

HUHTAMÄKI OYJ PRESS RELEASE 23.9.2021 AT 20:15

CORRECTION: Huhtamaki completes the acquisition of Elif, a major supplier of sustainable flexible packaging to global brand owners

In Huhtamäki Oyj’s press release concerning the closure of the acquisition of Elif published on September 23, 2021 at 17:30 EET, the cash free debt free purchase price was incorrect.

The incorrect sentence was: The cash free debt free purchase price was EUR 360 million (USD 422 million).

The correct sentence is: The cash free debt free purchase price was EUR 412 million (USD 483 million).

Below the corrected release in full:

Further to the full approval of the Turkish competition authority Huhtamaki has completed the acquisition of Elif Holding A.Ş. (Elif), a major supplier of sustainable flexible packaging to global FMCG brand owners, with operations in Turkey and in Egypt. With this acquisition, Huhtamaki reinforces its position as a leading flexible packaging company in emerging markets and strengthens its existing flexible packaging business in attractive consumer product categories.

The net sales of the acquired business were approximately EUR 163 million (USD 195 million) in 2020. Elif employs approximately 1,500 people in its two manufacturing locations in Istanbul, Turkey and Cairo, Egypt. The cash free debt free purchase price was EUR 412 million (USD 483 million). The acquired business will be reported as part of Huhtamaki´s Flexible Packaging business segment as of September 23, 2021.

For further information, please contact:
Media: Katariina Hietaranta, Head of Media Relations, tel. +358 10 686 7863
Investors: Calle Loikkanen, Head of IR and Financial Communications, tel. +358 10 686 7125

HUHTAMÄKI OYJ
Global Communications

About Huhtamaki
Huhtamaki is a key global provider of sustainable packaging solutions for consumers around the world, enabling wellbeing and convenience. Our innovative products protect on-the-go and on-the-shelf food and beverages, ensuring hygiene and safety, and help prevent food waste. We embed sustainability in everything we do. We are committed to achieving carbon neutral production and designing all our products to be recyclable, compostable or reusable by 2030.

We are a participant in the UN Global Compact and as of 2020, we received an MSCI ESG Rating of A, on a scale of AAA ─ CCC. To play our part in managing climate change, we have committed to set science-based targets through the Science Based Targets initiative. Huhtamaki has been awarded the Gold medal by EcoVadis for performance in sustainability.

With 100 years of history and a strong Nordic heritage we operate in 36 countries and 82 sites around the world. Our values Care Dare Deliver guide our decisions and help our team of 18,200 employees make a difference where it matters. Our 2020 net sales totaled EUR 3.3 billion. Huhtamaki Group is headquartered in Espoo, Finland and our parent company, Huhtamäki Oyj, is listed on Nasdaq Helsinki Ltd. Find out more about how we are protecting food, people and the planet on www.huhtamaki.com.

About Elif
Elif is a global benchmark flexible packaging company. In its two world-class plants with state-of-the-art machinery in Istanbul and Cairo, approximately 1,500 employees produce flexible packaging that is used in more than 200 production sites in over 50 countries.

Elif has a turnover of USD 195m and an export ratio of 62 percent in 2020. Elif enables customers to reach their sustainability goals by using more recycled content, bio-based materials, bio-degradable green PE, and fully recyclable HyPEr/PE laminate structures. Elif’s goal, to be achieved by 2025, is to develop packaging that is 100 percent recyclable, reusable, or compostable. Elif is a member of various initiatives and associations that advocate sustainable solutions and a circular economy, including Save Food, CEFLEX, UNGC, and UNICEF.

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Bombardier to Report Third Quarter 2021 Financial Results on October 28, 202121.10.2021 23:04:58 CEST | Press release

MONTRÉAL, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Bombardier (TSX: BBD.B) will publish its financial results for the third quarter ended September 30, 2021, on October 28, 2021. On October 28, 2021, at 8:00 a.m., EST, Bombardier will hold a webcast/conference call intended for investors and financial analysts to review the company’s financial results for the third quarter September 30, 2021. A live webcast of the call and relevant financial charts will be available at ir.bombardier.com. Stakeholders wishing to listen to the presentation and the question-and-answer period by telephone may dial one of the following conference call numbers: In English:514-392-1587, passcode: 4225431# or 1-877-395-0279, passcode: 4225431# (toll-free in North America) Overseas calls: 800 4222 8835, code 4225431# Look up country phone numberIn French: (with translation)514-861-1381, passcode: 5075227# or 1-877-695-6175, passcode: 5075227# (toll-free in North America) Overseas calls: +800 4222 8835, passcode 507522

Babylon stänger affärskombination och kommer påbörja handel på New York Stock Exchange under tickern BBLN21.10.2021 22:30:00 CEST | Pressemelding

Kinnevik AB (publ) ("Kinnevik") meddelade idag att Babylon slutfört sitt samgående med förvärvsbolaget (Eng. Special Purpose Acquisition Company) Alkuri Global Acquisition Corp. Transaktionen godkändes den 20 oktober 2021 av Alkuris aktieägare. Babylons stamaktier av klass A och dess teckningsoptioner kommer att börja handlas på New York -börsen ("NYSE") den 22 oktober 2021 under de nya tickersymbolerna "BBLN" respektive "BBLN.W". Efter transaktionen kommer Kinnevik inneha 54 240 640 A-aktier i bolaget. För mer information från bolaget se https://www.babylonhealth.com/press/press-room Kinneviks vd Georgi Ganev kommenterade: ”Vi fortsätter att imponeras av Babylon Healths grundare och vd, Ali Parsa, och hans teams engagemang för att tillhandahålla prisvärd, tillgänglig och datadriven vård. Babylon Health kommer nu att vara väl kapitaliserat och vi välkomnar nya aktieägare till nästa kapitel av bolagets tillväxtresa. ” För ytterligare information, besök www.kinnevik.com eller kontakta: T

Babylon Closes Business Combination and Will Begin Trading on the New York Stock Exchange Under the Ticker BBLN21.10.2021 22:30:00 CEST | Press release

Kinnevik AB (publ) ("Kinnevik”) today announced that Babylon it has completed its business combination with Alkuri Global Acquisition Corp, a special purpose acquisition company. The transaction was approved on October 20, 2021 by Alkuri’s shareholders. Babylon’s shares of Class A common stock and its warrants will begin trading on the New York Stock Exchange (“NYSE”) on October 22, 2021 under the new ticker symbols “BBLN” and “BBLN.W”, respectively. After the closing of the transaction, Kinnevik will hold 54,240,640 A shares in the company. For full information from the company, please see https://www.babylonhealth.com/press/press-room Georgi Ganev, CEO of Kinnevik commented: “We continue to be impressed by the founder and CEO of Babylon Health, Ali Parsa’s and his team’s dedication to provide affordable, accessible and data-driven healthcare. Babylon Health will now be well capitalized and we welcome new shareholders in the next chapter of its growth journey.” For further information

CrossAmerica Partners LP Maintains Quarterly Distribution21.10.2021 22:20:00 CEST | Press release

• Quarterly distribution of $0.5250 per unit attributable to the third quarter of 2021 Allentown, Oct. 21, 2021 (GLOBE NEWSWIRE) -- CrossAmerica Partners LP Maintains Quarterly Distribution Quarterly distribution of $0.5250per unit attributable to the thirdquarter of 2021 ALLENTOWN, PA (October 21, 2021) – CrossAmerica Partners LP (NYSE: CAPL) announced today that the Board of Directors of its general partner has approved a quarterly distribution of $0.5250 per unit attributable to the third quarter of 2021 (annualized $2.10 per unit). The distribution attributable to the third quarter is payable on November 10, 2021 to all unitholders of record on November 3, 2021. CrossAmerica will host a conference call on November 9th at 9:00 a.m. Eastern Time to discuss second quarter earnings results, which will be released after the market closes on Monday, November 8. About CrossAmerica Partners LP CrossAmerica Partners is a leading wholesale distributor of motor fuels, convenience store operat

Industrivärden avser att kalla till extra bolagsstämma för beslut om indragning av från Handelsbanken erhållna Industrivärdenaktier21.10.2021 20:30:00 CEST | Pressemelding

Industrivärden avser att kalla till en extra bolagsstämma för beslut om minskning av aktiekapitalet genom indragning av de A-aktier i Industrivärden som Industrivärden kommer att erhålla genom extra utdelning från innehavsbolaget Handelsbanken. Åtgärden syftar till att Industrivärdens aktieägare på bästa sätt ska kunna tillgodogöra sig det mottagna värdet. Styrelsens fullständiga förslag kommer att offentliggöras i samband med den kommande kallelsen till en extra bolagsstämma i Industrivärden. Idag beslutade en extra bolagsstämma i Handelsbanken att lämna en extrautdelning till sina aktieägare i form av A-aktier i Industrivärden. Därigenom kommer Industrivärden att erhålla 3.310.769 egna A-aktier, motsvarande ett värde om cirka 930 miljoner kronor. Industrivärdens styrelse har utvärderat olika alternativ för att dess aktieägare ska kunna tillgodogöra sig värdet av mottagna Industrivärdenaktier på bästa sätt. Utifrån dessa överväganden, som bland annat innefattar att Industrivärdens A-a

Industrivärden intends to convene an Extraordinary General Meeting for resolution on cancellation of the Industrivärden shares received from Handelsbanken21.10.2021 20:30:00 CEST | Press release

Industrivärden intends to convene an Extraordinary General Meeting to resolve on a reduction of the share capital by way of cancellation of the Class A shares in Industrivärden that Industrivärden will receive through extra dividend from the portfolio company Handelsbanken. The purpose is to enable the shareholders in Industrivärden to benefit from the received value in the best possible way. The Board of Directors’ complete proposals will be made available in connection with the forthcoming notice to an Extraordinary General Meeting in Industrivärden. An Extraordinary General Meeting in Handelsbanken today resolved on an extra dividend to its shareholders in the form of Class A shares in Industrivärden. Industrivärden will thereby receive 3,310,769 own Class A shares, corresponding to a value of approximately SEK 930 million. The Board of Directors in Industrivärden has evaluated different alternatives in order for its shareholders to benefit from the value of the received Industrivär

Palette Life Sciences tillkännager slutförandet av en finansiering på 30 miljoner dollar och utökning av styrelsen21.10.2021 18:08:47 CEST | Pressemelding

Pengarna ska användas för att utöka kommersiella avtryck i USA och påskynda den kliniska utvecklingen av Barrigel® SANTA BARBARA, KALIFORNIEN och STOCKHOLM, Sverige, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Palette Life Sciences, ett företag med säte i Sverige, som arbetar med att förbättra patientutfall, tillkännagav idag att bolaget har slutfört en finansiering på 30 miljoner dollar i eget kapital under våren och även utökat sin styrelse med fem medlemmar. ”Kapitalanskaffningen gör det möjligt för oss att fortsätta att expandera Palette Life Sciences kommersiella närvaro i USA och på andra viktiga marknader och ta produkter som Barrigel® till den globala marknaden”, säger Per G. Langö, Chief Executive Officer och styrelseledamot för Palette Life Sciences. ”Vi är glada över att stärka vårt team med utnämningen av exceptionella ledare. De kommer att tillföra avsevärd expertis inom sina respektive funktioner medan vi utökar vår produktportfölj och levererar bästa möjliga vård till våra patient